APA

Rodger M. A., Le Gal G., Carrier M., Betancourt M. T., Kahn S. R., Wells P. S., Anderson D. A., Lacut K., Chagnon I., Solymoss S., Crowther M., Perrier A., White R., Vickars L., Ramsay T. & Kovacs M. J. (20101228). Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE. : Thrombosis research.

Chicago

Rodger M A, Le Gal G, Carrier Marc, Betancourt M T, Kahn S R, Wells P S, Anderson D A, Lacut K, Chagnon I, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T and Kovacs M J. 20101228. Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE. : Thrombosis research.

Harvard

Rodger M. A., Le Gal G., Carrier M., Betancourt M. T., Kahn S. R., Wells P. S., Anderson D. A., Lacut K., Chagnon I., Solymoss S., Crowther M., Perrier A., White R., Vickars L., Ramsay T. and Kovacs M. J. (20101228). Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE. : Thrombosis research.

MLA

Rodger M A, Le Gal G, Carrier Marc, Betancourt M T, Kahn S R, Wells P S, Anderson D A, Lacut K, Chagnon I, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T and Kovacs M J. Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE. : Thrombosis research. 20101228.